Frontiers in Pain Research,
Journal Year:
2023,
Volume and Issue:
4
Published: Oct. 11, 2023
Introduction
Intermediate
efficacy
mu
opioid
receptor
(MOR)
agonists
have
potential
to
retain
analgesic
effectiveness
while
improving
safety,
but
the
optimal
MOR
for
effective
and
safe
analgesia
is
unknown.
Preclinical
assays
of
pain-depressed
behavior
can
assess
effects
opioids
other
candidate
analgesics
on
pain-related
behavioral
depression,
which
a
common
manifestation
clinically
relevant
pain
target
treatment.
Accordingly,
present
study
goal
was
validate
novel
assay
locomotor
in
mice
evaluate
role
as
determinant
related
safety
measures.
Methods
Male
female
ICR
were
tested
chamber
consisting
2
compartments
connected
by
doorway
that
contained
1-inch-tall
barrier.
Dependent
measures
during
15-min
sessions
included
crosses
between
(which
required
vertical
activity
surmount
barrier)
total
movement
counts
horizontal
break
photobeams
each
compartment).
Results
Discussion
Intraperitoneal
injection
lactic
acid
(IP
acid)
produced
concentration-
time-dependent
depression
both
endpoints.
Optimal
blockade
IP
acid-induced
with
minimal
motor
impairment
achieved
intermediate-efficacy
treatments
also
less
gastrointestinal-transit
inhibition
respiratory
than
high-efficacy
agonist
fentanyl.
Sex
differences
treatment
rare.
Overall,
these
findings
procedure
evaluating
support
continued
research
strategy
improved
safety.
Frontiers in Pain Research,
Journal Year:
2023,
Volume and Issue:
4
Published: Sept. 22, 2023
Neuropathic
pain
can
result
from
injury
to,
or
disease
of
the
nervous
system.
It
is
notoriously
difficult
to
treat.
Peripheral
nerve
promotes
Schwann
cell
activation
and
invasion
immunocompetent
cells
into
site
injury,
spinal
cord
higher
sensory
structures
such
as
thalamus
cingulate
cortices.
Various
cytokines,
chemokines,
growth
factors,
monoamines
neuropeptides
effect
two-way
signalling
between
neurons,
glia
immune
cells.
This
sustained
hyperexcitability
spontaneous
activity
in
primary
afferents
that
crucial
for
onset
persistence
well
misprocessing
information
supraspinal
structures.
Much
current
understanding
aetiology
identification
drug
targets
derives
studies
consequences
peripheral
rodent
models.
Although
a
vast
amount
has
been
forthcoming,
translation
this
clinical
arena
minimal.
Few,
if
any,
major
therapeutic
approaches
have
appeared
since
mid
1990's.
may
reflect
failure
recognise
differences
processing
males
vs.
females,
cellular
responses
different
types
humans
animals.
Basic
science
which
seek
bridge
knowledge
gap
include
better
assessment
animal
models,
use
models
emulate
human
disease,
stratification
phenotypes
according
quantitative
signs
symptoms
disease.
lead
more
personalized
effective
treatments
individual
patients.
Significance
statement:
There
an
urgent
need
find
new
neuropathic
pain.
classical
revealed
essential
features
central
sensitization
some
molecular
mechanisms
involved,
they
do
not
adequately
model
multiplicity
states
injuries
bring
forth
clinic.
review
seeks
integrate
disciplines
understand
pain;
including
immunology,
biology,
electrophysiology
biophysics,
anatomy,
neurology,
pharmacology
behavioral
science.
Beyond
this,
it
underlines
ongoing
refinements
basic
practice
will
engender
improved
management.
Science Translational Medicine,
Journal Year:
2024,
Volume and Issue:
16(766)
Published: Sept. 25, 2024
Neuroimmune
interactions
are
essential
for
the
development
of
neuropathic
pain,
yet
contributions
distinct
immune
cell
populations
have
not
been
fully
unraveled.
Here,
we
demonstrate
critical
role
B
cells
in
promoting
mechanical
hypersensitivity
(allodynia)
after
peripheral
nerve
injury
male
and
female
mice.
Depletion
with
a
single
injection
anti-CD20
monoclonal
antibody
at
time
prevented
allodynia.
cell–deficient
(muMT)
mice
were
similarly
spared
from
Nerve
was
associated
increased
immunoglobulin
G
(IgG)
accumulation
ipsilateral
lumbar
dorsal
root
ganglia
(DRGs)
spinal
cords.
IgG
colocalized
sensory
neurons
macrophages
DRGs
microglia
also
accumulated
DRG
samples
human
donors
chronic
colocalizing
marker
satellite
glia.
RNA
sequencing
revealed
population
naive
mouse
DRGs.
A
transcriptional
signature
enriched
pain.
Passive
transfer
injured
induced
allodynia
muMT
recipient
The
pronociceptive
effects
likely
mediated
through
complexes
interacting
Fc
gamma
receptors
(FcγRs)
expressed
by
neurons,
microglia,
macrophages,
given
that
both
hyperexcitability
dissociated
abolished
nerve-injured
FcγR-deficient
Consistently,
passive
lost
These
data
reveal
cell–IgG–FcγR
axis
is
required
pain
Cell & Bioscience,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 9, 2025
Abstract
Background
Neuropathic
pain
resulting
from
spinal
cord
injury
(SCI)
is
associated
with
persistent
hyperactivity
of
primary
nociceptors.
Anandamide
(AEA)
has
been
reported
to
modulate
neuronal
excitability
and
synaptic
transmission
through
activation
cannabinoid
type-1
receptors
(CB1Rs)
transient
receptor
potential
vanilloid
1
(TRPV1).
However,
the
role
AEA
these
in
nociceptors
after
SCI
remains
unclear.
Results
In
this
study,
we
investigated
effects
its
on
hyperexcitability
mouse
dorsal
root
ganglion
(DRG)
neurons
SCI.
Using
a
whole-cell
patch-clamp
technique,
found
that
timing
SCI-induced
paralleled
an
increase
endocannabinoid
content.
The
expression
TRPV1
CB1R
was
also
upregulated
at
different
time
points
High-dose
extracellular
administration
increased
naive
DRG
neurons,
leading
transition
rapidly
accommodating
(RA)
hypoexcitable
state
highly
excitable
non-accommodating
(NA)
state.
These
AEA-induced
transitions
were
facilitated
by
transcription.
Pharmacological
Ca
2+
imaging
experiments
revealed
induced
via
AEA-TRPV1-Ca
pathway,
whereas
CB1Rs
reduced
maintained
cytosolic
concentration
([Ca
]
cyto
)
low
levels
early
stages
As
SCI,
adaptive
neuroprotection
transitioned
maladaptive
hyperactive
state,
sustained
pain.
Conclusions
Taken
together,
study
provides
new
insights
into
how
endocannabinoids
regulate
nociceptor
activity
offering
targets
for
treatment
neuropathic
Neuron,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 1, 2025
Pain
hypersensitivity
arises
from
the
induction
of
plasticity
in
peripheral
and
spinal
somatosensory
neurons,
which
modifies
nociceptive
input
to
brain,
altering
pain
perception.
We
applied
longitudinal
calcium
imaging
dorsal
projection
neurons
determine
whether
how
representation
stimuli
anterolateral
tract,
principal
pathway
transmitting
signals
changes
between
distinct
states.
In
healthy
mice,
we
identified
stable
outputs
selective
for
cooling
or
warming
a
neuronal
ensemble
activated
by
noxious
thermal
mechanical
stimuli.
Induction
acute
sensitization
topical
capsaicin
transiently
re-tuned
output
encode
low-intensity
contrast,
nerve
injury
resulted
persistent
suppression
innocuous
coupled
with
activation
normally
silent
population
high-threshold
neurons.
These
results
demonstrate
differential
modulation
brain
during
neuropathic
Neurobiology of Pain,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100182 - 100182
Published: March 1, 2025
Voltage-gated
sodium
channel
isoform
1.8
(NaV1.8)
has
emerged
as
a
promising
pharmaceutical
target
for
the
treatment
of
acute
and
chronic
pain.
However,
highly
selective
potent
inhibitors
this
have
been
difficult
to
develop
only
recently
advanced
clinical
testing.
Our
efforts
NaV1.8
small
molecule
yielded
series
molecules
with
favorable
in
vitro
potency
selectivity
against
human
but
exhibited
dramatic
rightward
shifts
rodent
channel,
severely
limiting
vivo
screening
candidate
selection.
In
anticipation
supporting
drug
discovery
efforts,
transgenic
rat
line
expressing
lieu
was
developed.
Utilizing
these
humanized
animals,
our
chemical
matter
freshly
isolated
DRG
neurons
consistent
values,
enabling
work
progress.
We
demonstrate
capsaicin-induced
nocifensive
behaviors
(CNB)
moderate
throughput
assay,
from
which
we
pharmacokinetic-pharmacodynamic
(PK-PD)
vitro-in
correlation
(IVIVC)
relationships.
identified
MSD199
inhibitor
pain
efficacy
assessed
it
traditional
inflammatory
(Complete
Freund's
Adjuvant)
neuropathic
(spinal
nerve
ligation)
behavioral
assays
where
shown
significantly
reduce
pain-related
behaviors.
Overall,
utility
animals
when
cross-species
are
observed
within
an
otherwise
series.
Brain,
Journal Year:
2024,
Volume and Issue:
147(9), P. 2991 - 2997
Published: July 24, 2024
Abstract
Spontaneous
activity
in
dorsal
root
ganglion
(DRG)
neurons
is
a
key
driver
of
neuropathic
pain
patients
suffering
from
this
largely
untreated
disease.
While
many
intracellular
signalling
mechanisms
have
been
examined
preclinical
models
that
drive
spontaneous
activity,
none
tested
directly
on
spontaneously
active
human
nociceptors.
Using
cultured
DRG
recovered
during
thoracic
vertebrectomy
surgeries,
we
showed
inhibition
mitogen-activated
protein
kinase
interacting
(MNK)
with
tomivosertib
(eFT508,
25
nM)
reversibly
suppresses
sensory
are
likely
nociceptors
based
size
and
action
potential
characteristics
associated
painful
dermatomes
within
minutes
treatment.
Tomivosertib
treatment
also
decreased
amplitude
produced
alterations
the
magnitude
after
hyperpolarizing
currents,
suggesting
modification
Na+
K+
channel
as
consequence
drug
Parallel
to
effects
electrophysiology,
eFT508
led
profound
loss
eIF4E
serine
209
phosphorylation
primary
neurons,
specific
substrate
MNK,
2
min
Our
results
create
compelling
case
for
future
testing
MNK
inhibitors
clinical
trials
pain.
Pain,
Journal Year:
2023,
Volume and Issue:
165(4), P. 893 - 907
Published: Oct. 20, 2023
Abstract
Nociceptor
cell
bodies
generate
“spontaneous”
discharge
that
can
promote
ongoing
pain
in
persistent
conditions.
Little
is
known
about
the
underlying
mechanisms.
Recordings
from
nociceptor
(somata)
dissociated
rodent
and
human
dorsal
root
ganglia
have
shown
previous
vivo
associated
with
low-frequency
controlled
by
irregular
depolarizing
spontaneous
fluctuations
of
membrane
potential
(DSFs),
likely
produced
transient
inward
currents
across
somal
input
resistance.
Using
mouse
nociceptors,
we
show
DSFs
are
high
resistance
over
a
wide
range
potentials,
including
depolarized
levels
where
approach
action
(AP)
threshold.
Input
both
amplitude
frequency
were
increased
neurons
exhibiting
activity.
Ion
substitution
experiments
indicated
phase
generated
opening
channels
permeable
to
Na
+
or
Ca
2+
-permeable
especially
important
for
larger
DSFs.
Partial
reduction
perfusion
pharmacological
inhibitors
small
but
significant
contributions
Nav1.7,
Nav1.8,
TRPV1,
TRPA1,
TRPM4,
N-type
channels.
Less
specific
blockers
suggested
contribution
NALCN
channels,
global
knockout
role
Nav1.9.
The
combination
plus
background
activity
diverse
ion
produces
poised
reach
AP
threshold
if
resting
depolarizes,
decreases,
become
enhanced—all
which
occur
under
painful
neuropathic
inflammatory
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: June 14, 2023
Abstract
Spontaneous
activity
in
dorsal
root
ganglion
(DRG)
neurons
is
a
key
driver
of
neuropathic
pain
preclinical
models
and
patients
suffering
from
this
largely
untreated
disease.
While
many
intracellular
signaling
mechanisms
have
been
examined
that
drive
spontaneous
(SA),
none
these
tested
directly
on
spontaneously
active
human
nociceptors.
Using
cultured
DRG
recovered
during
thoracic
vertebrectomy
surgeries,
we
show
inhibition
mitogen
activated
protein
kinase
interacting
(MNK)
with
eFT508
(25
nM)
reverses
SA
sensory
associated
painful
dermatomes.
MNK
nociceptors
decreased
action
potential
amplitude
produced
alterations
the
magnitude
afterhyperpolarizing
currents
suggesting
modification
Na
+
K
channel
downstream
inhibition.
The
effects
took
minutes
to
emerge
were
reversible
over
time
washout.
led
profound
loss
eIF4E
Serine
209
phosphorylation,
specific
target
kinase,
within
2
min
drug
treatment,
consistent
rapid
electrophysiology
experiments.
Our
results
create
compelling
case
for
future
testing
inhibitors
clinical
trials
pain.
Conflict
interest
TJP
co-founder
4E
Therapeutics,
company
developing
other
authors
declare
no
conflicts
interest.